Buy Or Sell Opportunity • May 05
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 3.7% to €13.04. The fair value is estimated to be €10.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.5% per annum. Earnings are also forecast to grow by 18% per annum over the same time period. Upcoming Dividend • Apr 27
Upcoming dividend of €0.20 per share Eligible shareholders must have bought the stock before 04 May 2026. Payment date: 06 May 2026. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.6%). Buy Or Sell Opportunity • Apr 07
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 15% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 18% per annum over the same time period. Buy Or Sell Opportunity • Mar 16
Now 28% overvalued after recent price rise Over the last 90 days, the stock has risen 20% to €13.04. The fair value is estimated to be €10.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 18% per annum over the same time period. Declared Dividend • Mar 08
Dividend of €0.20 announced Dividend of €0.20 is the same as last year. Ex-date: 4th May 2026 Payment date: 6th May 2026 Dividend yield will be 1.6%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (16% cash payout ratio). The dividend has increased by an average of 5.9% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 43% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Duyuru • Mar 07
Intercos S.p.A. announces Annual dividend, payable on May 06, 2026 Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 06, 2026, ex-date on May 04, 2026 and record date on May 05, 2026. Reported Earnings • Mar 07
Full year 2025 earnings released Full year 2025 results: Revenue: €1.05b (down 1.7% from FY 2024). Net income: €50.1m (up 3.2% from FY 2024). Profit margin: 4.8% (up from 4.6% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Personal Products industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.23 per share. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.48 per share. New Risk • Dec 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 11x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.41 per share. Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €13.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 10x in the Personal Products industry in the United Kingdom. Total returns to shareholders of 4.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.82 per share. Buy Or Sell Opportunity • Oct 29
Now 29% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to €13.04. The fair value is estimated to be €10.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 7.1% in 2 years. Earnings are forecast to grow by 61% in the next 2 years. Buy Or Sell Opportunity • Oct 13
Now 30% overvalued after recent price rise Over the last 90 days, the stock has risen 6.4% to €13.04. The fair value is estimated to be €10.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 6.9% in 2 years. Earnings are forecast to grow by 58% in the next 2 years. Buy Or Sell Opportunity • Sep 08
Now 31% overvalued Over the last 90 days, the stock has fallen 3.8% to €13.04. The fair value is estimated to be €9.94, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 8.0%. Revenue is forecast to grow by 8.6% in 2 years. Earnings are forecast to grow by 62% in the next 2 years. Reported Earnings • Aug 11
First half 2025 earnings released: EPS: €0.17 (vs €0.18 in 1H 2024) First half 2025 results: EPS: €0.17 (down from €0.18 in 1H 2024). Revenue: €524.9m (up 5.0% from 1H 2024). Net income: €16.5m (down 6.9% from 1H 2024). Profit margin: 3.1% (down from 3.5% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Personal Products industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jul 30
Now 27% overvalued Over the last 90 days, the stock has fallen 1.7% to €13.04. The fair value is estimated to be €10.24, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period. Buy Or Sell Opportunity • Jul 15
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 9.4% to €13.04. The fair value is estimated to be €10.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 15% per annum over the same time period. Buy Or Sell Opportunity • May 09
Now 22% overvalued Over the last 90 days, the stock has fallen 2.3% to €13.20. The fair value is estimated to be €10.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Upcoming Dividend • Apr 28
Upcoming dividend of €0.20 per share Eligible shareholders must have bought the stock before 05 May 2025. Payment date: 07 May 2025. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (6.0%). Lower than average of industry peers (2.3%). Buy Or Sell Opportunity • Apr 23
Now 22% overvalued Over the last 90 days, the stock has fallen 9.1% to €13.04. The fair value is estimated to be €10.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 5.9% per annum. Earnings are also forecast to grow by 18% per annum over the same time period. Declared Dividend • Mar 08
Dividend increased to €0.20 Dividend of €0.20 is 5.4% higher than last year. Ex-date: 5th May 2025 Payment date: 7th May 2025 Dividend yield will be 1.5%, which is lower than the industry average of 1.9%. Sustainability & Growth Dividend is well covered by both earnings (40% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 8.9% per year over the past 2 years and payments have been stable during that time. EPS is expected to grow by 39% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 06
Full year 2024 earnings released Full year 2024 results: Revenue: €1.06b (up 7.8% from FY 2023). Net income: €48.8m (down 6.8% from FY 2023). Profit margin: 4.6% (down from 5.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in the United Kingdom. Duyuru • Mar 06
Intercos S.p.A. announces Annual dividend, payable on May 07, 2025 Intercos S.p.A. announced Annual dividend of EUR 0.1972 per share payable on May 07, 2025, ex-date on May 05, 2025 and record date on May 06, 2025. Reported Earnings • Aug 05
First half 2024 earnings released First half 2024 results: Revenue: €499.9m (up 2.4% from 1H 2023). Net income: €17.9m (down 28% from 1H 2023). Profit margin: 3.6% (down from 5.1% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom. Buy Or Sell Opportunity • Aug 05
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 22% to €16.44. The fair value is estimated to be €13.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 77% in the next 2 years. Reported Earnings • May 11
First quarter 2024 earnings released: EPS: €0.05 (vs €0.13 in 1Q 2023) First quarter 2024 results: EPS: €0.05 (down from €0.13 in 1Q 2023). Revenue: €403.8m (up 65% from 1Q 2023). Net income: €2.81m (down 77% from 1Q 2023). Profit margin: 0.7% (down from 5.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom. Duyuru • Mar 27
Intercos S.p.A. to Report Fiscal Year 2023 Results on Apr 11, 2024 Intercos S.p.A. announced that they will report fiscal year 2023 results on Apr 11, 2024 Declared Dividend • Mar 07
Dividend increased to €0.19 Dividend of €0.19 is 12% higher than last year. Ex-date: 6th May 2024 Payment date: 8th May 2024 Dividend yield will be 1.3%, which is lower than the industry average of 1.9%. Payout Ratios Payout ratio: 31%. Cash payout ratio: 35%. Reported Earnings • Aug 06
First half 2023 earnings released First half 2023 results: Revenue: €488.4m (up 33% from 1H 2022). Net income: €25.0m (up 38% from 1H 2022). Profit margin: 5.1% (up from 4.9% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 21x in the Personal Products industry in Europe. Board Change • Jul 03
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jun 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • May 31
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • May 04
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €13.04, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Personal Products industry in Europe. Valuation Update With 7 Day Price Move • Apr 19
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to €16.10, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Personal Products industry in Europe. Reported Earnings • Mar 16
Full year 2022 earnings released Full year 2022 results: Revenue: €835.6m (up 24% from FY 2021). Net income: €45.0m (up 67% from FY 2021). Profit margin: 5.4% (up from 4.0% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom. Duyuru • Feb 13
Intercos S.p.A. to Report Fiscal Year 2022 Results on Mar 14, 2023 Intercos S.p.A. announced that they will report fiscal year 2022 results on Mar 14, 2023 Board Change • Jan 25
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Nov 30
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €10.84, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €8.85 per share. Board Change • Oct 14
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment improved over the past week After last week's 22% share price gain to €13.04, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €12.42 per share. Board Change • Sep 01
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 06
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down €17.5m from profit in 1H 2021). Profit margin: (down from 5.5% in 1H 2021). Over the next year, revenue is forecast to grow 11%, compared to a 5.7% growth forecast for the industry in the United Kingdom. Board Change • Jul 22
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jun 08
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 8 non-independent directors. Independent Director Michele Scannavini was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.